The Plasminogen Activation System Modulates Differently Adipogenesis and Myogenesis of Embryonic Stem Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Hadadeh, Ola ^a,b   Barruet, Emilie ^a,b   Peiretti, Franck ^a,b   Verdier, Monique ^a,b   Bernot, Denis ^a,b   Hadjal, Yasmine ^a,b   Yazidi, Claire El ^a,b   Robaglia Schlupp, Andrée ^a,c   de Paula, Andre Maues ^a,c   Nègre, Didier ^d,e   Iacovino, Michelina ^f   Kyba, Michael ^f   Alessi, Marie Christine ^a,b   Binétruy, Bernard ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMILORIDE; COLLAGEN TYPE 1; COMPLEMENTARY DNA; DOXYCYCLINE; MEMBRANE PROTEIN; MESSENGER RNA; MYOGENIN; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 1; OCTAMER TRANSCRIPTION FACTOR 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BRACHYURY; PROTEIN MESP1; PROTEIN TBX1; RETINOIC ACID; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE INDUCTION; HUMAN; IN VITRO STUDY; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; PLASMINOGEN ACTIVATION; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM;

EID: 84869040368     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049065     Document Type: Article

References (36)

1. Lensch M, Daheron L, Schlaeger T, (2006) Pluripotent stem cells and their niches. Stem Cell Reviews and Reports 2: 185-201.
2. Peerani R, Rao BM, Bauwens C, Yin T, Wood GA, et al. (2007) Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J 26: 4744-4755.
3. Mondino A, Blasi F, (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends in Immunology 25: 450-455.
4. Irigoyen J, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y, (1999) The plasminogen activator system: biology and regulation. Cell Mol Life Sci 56: 104-132.
5. Rifkin DB, Mazzieri R, Munger JS, Noguera I, Sung J, (1999) Proteolytic control of growth factor availability. APMIS 107: 80-85.
6. Chapman HA, Wei Y, (2001) Protease crosstalk with integrins: the urokinase receptor paradigm. Thromb Haemost 86: 124-129.
7. Stefansson S, Lawrence DA, (1996) The serpin PAI-1 inhibits cell migration by blocking integrin [alpha]v[beta]3 binding to vitronectin. Nature 383: 441-443.
8. Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, et al. (2002) The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proceedings of the National Academy of Sciences of the United States of America 99: 1359-1364.
9. Liang X, Kanjanabuch T, Mao SL, Hao CM, Tang YW, et al. (2006) Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab 290: E103-E113. Epub 2005 Sep 2006.
10. McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, et al. (2001) Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 276: 33964-33968.
11. Isogai C, Laug WE, Shimada H, Declerck PJ, Stins MF, et al. (2001) Plasminogen Activator Inhibitor-1 Promotes Angiogenesis by Stimulating Endothelial Cell Migration toward Fibronectin. Cancer Res 61: 5587-5594.
12. Balsara RD, Castellino FJ, Ploplis VA, (2006) A Novel Function of Plasminogen Activator Inhibitor-1 in Modulation of the AKT Pathway in Wild-type and Plasminogen Activator Inhibitor-1-deficient Endothelial Cells 10.1074/jbc.M512819200. J Biol Chem 281: 22527-22536.
13. Bonavaud S, Charriere-Bertrand C, Rey C, Leibovitch MP, Pedersen N, et al. (1997) Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. J Cell Sci 110: 1083-1089.
14. Suelves M, Lopez-Alemany R, Lluis F, Aniorte G, Serrano E, et al. (2002) Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. Blood 99: 2835-2844.
15. Fibbi G, Barletta E, Dini G, Del Rosso A, Pucci M, et al. (2001) Cell Invasion Is Affected by Differential Expression of the Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor System in Muscle Satellite Cells from Normal and Dystrophic Patients. Lab Invest 81: 27-39.
16. Lluis F, Roma J, Suelves M, Parra M, Aniorte G, et al. (2001) Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood 97: 1703-1711.
17. Koh TJ, Bryer SC, Pucci AM, Sisson TH (2005) Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. Am J Physiol Cell Physiol 289: C217-223. Epub 2005 Feb 2016.
18. Wobus AM, Boheler KR, (2005) Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85: 635-678.
19. Kashyap V, Rezende N, Scotland K, Shaffer S, Persson J, et al. (2009) Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cell and Development 18: 1093-1108.
20. Wobus AM, (2001) Potential of embryonic stem cells. Mol Aspects Med 22: 149-164.
21. Bost F, Caron L, Marchetti I, Dani C, Le Marchand-Brustel Y, et al. (2002) Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem J 361: 621-627.
22. Iacovino M, Bosnakovski D, Fey H, Rux D, Bajwa G, et al. (2011) Inducible cassette exchange: a rapid and efficient system enabling conditional gene expression in embryonic stem and primary cells. Stem Cells in press.
23. Caron L, Bost F, Prot M, Hofman P, Binetruy B, (2005) A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells. Oncogene 24: 6281-6291.
24. Aouadi M, Bost F, Caron L, Laurent K, Le Marchand Brustel Y, et al. (2006) p38 Mitogen-Activated Protein Kinase Activity Commits Embryonic Stem Cells to Either Neurogenesis or Cardiomyogenesis. Stem Cells 24: 1399-1406. Epub 2006 Jan 1319.
25. Nar H, Bauer M, Stassen J-M, Lang D, Gils A, et al. (2000) Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation. Journal of Molecular Biology 297: 683-695.
26. Barruet E, Hadadeh O, Peiretti F, Renault VM, Hadjal Y, et al. (2011) p38 mitogen activated protein kinase controls two successive-steps during the early mesodermal commitment of embryonic stem cells. Stem Cells Dev 20: 1233-1246.
27. Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D, et al. (2000) Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 20: 1150-1154.
28. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, et al. (2009) Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A 106: 157-162.
29. Halvorsen B, Staff AC, Henriksen T, Sawamura T, Ranheim T, (2001) 8-iso-Prostaglandin F2α Increases Expression of LOX-1 in JAR Cells. Hypertension 37: 1184-1190.
30. Dani C, Smith AG, Dessolin S, Leroy P, Staccini L, et al. (1997) Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci 110: 1279-1285.
31. Aouadi M, Laurent K, Prot M, Le Marchand-Brustel Y, Binetruy B, et al. (2006) Inhibition of p38MAPK Increases Adipogenesis From Embryonic to Adult Stages10.2337/diabetes.55.02.06.db05-0963. Diabetes 55: 281-289.
32. Vassalli J-D, Belin D, (1987) Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS letters 214: 187-191.
33. Ishida T, Tsukada H, Hasegawa T, Yoshizawa H, Gejyo F, (2006) Matrix Metalloproteinase-1 Activation via Plasmin Generated on Alveolar Epithelial Cell Surfaces. Lung 184: 15-19.
34. Binder BR, Mihaly J, Prager GW, (2007) uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost 97: 336-342.
35. Lopez-Alemany R, Redondo JM, Nagamine Y, Munoz-Canoves P, (2003) Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with v3 integrin for vitronectin binding. European Journal of Biochemistry 270: 814-821.
36. Kennedy K, Porter T, Mehta V, Ryan S, Price F, et al. (2009) Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin. BMC Biology 7: 67.